Table 3 of Jiang, Mol Vis 2010; 16:2092-2108.
Probe Set ID | Gene | Annotation | Glau_avg | Cont_avg | Fold Change | q-value(%) |
---|---|---|---|---|---|---|
RGC genes | ||||||
CfaAff × 0.30898.1.S1_at | CALB2 | “calbindin 2, (calretinin)” | 7.4 | 9.5 | 3.8 | 0 |
CfaAff × 0.29820.1.S1_s_at | CIRBP | cold inducible RNA binding protein | 9.0 | 10.3 | 2.3 | 0 |
CfaAff × 0.27495.1.S1_at | CPLX3 | complexin 3 | 9.1 | 10.5 | 2.3 | 0 |
Cfa.12330.1.A1_s_at | EBF1 | early B-cell factor 1 | 5.1 | 7.2 | 4.3 | 0 |
Cfa.9181.1.A1_at | ELAVL2 | “ELAV (embryonic lethal, abnormal vision)-like 2” | 6.7 | 9.2 | 4.6 | 0 |
Cfa.19294.1.S1_s_at | ELAVL4 | “ELAV (embryonic lethal, abnormal vision)-like 4” | 6.1 | 9.2 | 6.3 | 0 |
*Cfa.299.1.A1_at | FABP3* | “fatty acid binding protein 3, muscle and heart” | 7.6 | 9.4 | 2.9 | 0 |
Cfa.1153.1.A1_at | FKBP1B | “FK506 binding protein 1B, 12.6 kDa” | 8.3 | 10.2 | 3.5 | 0 |
*Cfa.5865.1.A1_at | KIF5A* | kinesin family member 5A | 6.7 | 8.5 | 2.8 | 0 |
Cfa.10948.1.S1_at | LOC610447 | Visinin-like protein 1 (VILIP) | 7.5 | 11.5 | 9.9 | 0 |
*CfaAff × 0.19019.1.S1_s_at | NEFH* | “neurofilament, heavy polypeptide 200kDa” | 6.6 | 7.9 | 2.3 | 0 |
Cfa.10952.1.A1_s_at | NEFL | “neurofilament, light polypeptide 68kDa” | 8.6 | 12.6 | 9.3 | 0 |
*Cfa.10905.1.A1_at | NEFM* | “neurofilament, medium polypeptide 150kDa” | 8.8 | 12.9 | 10.3 | 0 |
*Cfa.11184.1.A1_s_at | NELL2* | NEL-like 2 (chicken) | 6.9 | 8.8 | 3.7 | 0 |
Cfa.9043.1.A1_at | NRG1 | neuregulin 1 | 6.3 | 7.4 | 2.2 | 0 |
CfaAff × 0.14934.1.S1_at | NRN1 | neuritin 1 | 6.6 | 9.2 | 5.5 | 0 |
Cfa.12391.1.A1_s_at | RBPMS | RNA binding protein with multiple splicing | 6.8 | 7.7 | 2.0 | 0 |
*CfaAff × 0.11569.1.S1_s_at | SCN1B* | “sodium channel, voltage-gated, type I, beta” | 6.0 | 7.4 | 2.7 | 0 |
*CfaAff × 0.13307.1.S1_s_at | STMN2* | stathmin-like 2 | 8.9 | 10.4 | 3.1 | 0 |
*Cfa.4489.1.S1_at | UCHL1* | ubiquitin carboxyl-terminal esterase L1 | 11.4 | 12.7 | 2.6 | 0 |
Synapse and Synaptic Transmission | ||||||
*CfaAff × 0.21696.1.S1_at | ACHE* | acetylcholinesterase | 6.0 | 7.4 | 2.4 | 0 |
CfaAff × 0.11508.1.S1_s_at | CADPS | Ca2+dependent secretion activator | 8.6 | 10.4 | 3.3 | 0 |
CfaAff × 0.18352.1.S1_s_at | CPNE6 | copine VI (neuronal) | 6.8 | 7.9 | 2.1 | 0 |
Cfa.9427.1.A1_at | CRH | corticotropin releasing hormone | 6.5 | 8.6 | 3.8 | 0 |
Cfa.21295.1.S1_s_at | DRD1IP | dopamine receptor D1 interacting protein | 7.3 | 9.5 | 4.6 | 0 |
CfaAff × 0.4606.1.S1_at | GABBR2 | “gamma-aminobutyric acid (GABA) B receptor, 2” | 6.4 | 7.5 | 2.1 | 0 |
CfaAff × 0.26365.1.S1_at | GABRA1 | “gamma-aminobutyric acid (GABA) A receptor, alpha 1” | 5.4 | 7.7 | 4.3 | 0 |
*Cfa.11206.1.A1_at | GABRB3* | “gamma-aminobutyric acid (GABA) A receptor, beta 3” | 6.8 | 9.5 | 5.4 | 0 |
CfaAff × 0.26360.1.S1_s_at | GABRG2 | “gamma-aminobutyric acid (GABA) A receptor, gamma 2” | 6.3 | 8.4 | 4.1 | 0 |
CfaAff × 0.5585.1.S1_s_at | GABRR1 | “gamma-aminobutyric acid (GABA) receptor, rho 1” | 6.3 | 8.8 | 5.2 | 0 |
*Cfa.1206.2.A1_s_at | GAD1* | “glutamate decarboxylase 1 (brain, 67kDa)” | 5.7 | 8.1 | 4.4 | 0 |
*CfaAff × 0.13687.1.S1_at | GRIA2* | “glutamate receptor, ionotropic, AMPA 2” | 7.4 | 9.1 | 3.4 | 0 |
CfaAff × 0.22871.1.S1_at | GRIA4 | “glutamate receptor, ionotrophic, AMPA 4” | 6.2 | 7.6 | 2.5 | 0 |
CfaAff × 0.3513.1.S1_at | GRM8 | “glutamate receptor, metabotropic 8” | 5.2 | 7.8 | 5.5 | 0 |
CfaAff × 0.4263.1.S1_s_at | ICA1 | “islet cell autoantigen 1, 69kDa” | 6.1 | 7.6 | 2.7 | 0 |
Cfa.9545.1.A1_at | NOVA1 | neuro-oncological ventral antigen 1 | 7.0 | 8.2 | 2.3 | 0 |
CfaAff × 0.28644.1.S1_at | RAB33A | “RAB33A, member RAS oncogene family” | 7.1 | 8.2 | 2.1 | 0 |
CfaAff × 0.11242.1.S1_s_at | SYNPR | synaptoporin | 6.0 | 8.2 | 4.1 | 0 |
CfaAff × 0.18684.1.S1_s_at | SYT14 | synaptotagmin XIV | 6.5 | 7.8 | 2.6 | 0 |
CfaAff × 0.27070.1.S1_at | SYT4 | synaptotagmin IV | 5.5 | 7.3 | 3.7 | 0 |
Cfa.4050.1.A1_a_at | TAC1 | “tachykinin, precursor 1” | 6.1 | 8.2 | 3.4 | 0 |
Phototransduction | ||||||
CfaAff × 0.25681.1.S1_at | ARR3 | “arrestin 3, retinal (X-arrestin)” | 10.3 | 12.9 | 2.1 | 0 |
Cfa.3480.1.A1_s_at | GNGT2 | “guanine nucleotide binding protein, gamma” | 10.3 | 12.3 | 2.4 | 0.064323389 |
CfaAff × 0.3367.1.S1_at | OPN1SW | “opsin 1, short-wave-sensitive” | 7.6 | 10.6 | 3.5 | 0.064323389 |
CfaAff × 0.12695.1.S1_s_at | PDE6C | cGMP-specific phosphodiesterase 6C | 7.1 | 8.6 | 2.0 | 0.064323389 |
Synucleins | ||||||
*CfaAff × 0.15497.1.S1_s_at | SNCA* | “synuclein, alpha “ | 5.8 | 7.4 | 2.9 | 0 |
*CfaAff × 0.25469.1.S1_s_at | SNCB* | “synuclein, beta” | 7.1 | 8.5 | 2.3 | 0 |
CfaAff × 0.24686.1.S1_at | SNCG | “synuclein, gamma” | 5.9 | 8.5 | 5.1 | 0 |
Growth Factors | ||||||
Cfa.19396.1.S1_s_at | FGF12 | fibroblast growth factor 12 | 5.5 | 7.0 | 2.9 | 0 |
*CfaAff × 0.9858.1.S1_s_at | FGF14* | fibroblast growth factor 14 | 6.8 | 8.0 | 2.2 | 0 |
*Cfa.3888.1.S1_at | IGF1* | insulin-like growth factor 1 (somatomedin C) | 4.8 | 6.5 | 3.5 | 0 |
CfaAff × 0.2203.1.S1_at | IL5 | “interleukin 5 (colony-stimulating factor, eosinophil)” | 5.0 | 7.2 | 4.4 | 0 |
*Cfa.4064.1.A1_at | PTN* | pleiotrophin (neurite growth-promoting factor 1) | 6.4 | 8.4 | 4.5 | 0 |
Cell Adhesion | ||||||
CfaAff × 0.14553.1.S1_at | AMIGO2 | adhesion molecule with Ig-like domain 2 | 6.4 | 8.1 | 3.2 | 0 |
CfaAff × 0.29067.1.S1_at | CDH12 | “cadherin 12, type 2 (N-cadherin 2)” | 6.1 | 7.7 | 2.9 | 0 |
CfaAff × 0.29091.1.S1_at | CDH18 | “cadherin 18, type 2” | 5.6 | 7.4 | 3.4 | 0 |
CfaAff × 0.1039.1.S1_at | CDH7 | “cadherin 7, type 2” | 7.4 | 8.6 | 2.4 | 0 |
Cfa.9512.1.A1_at | CTNNA2 | “catenin (cadherin-associated protein), alpha 2” | 7.3 | 8.8 | 3.1 | 0 |
Cfa.3718.1.S1_s_at | DSC2 | desmocollin 2 | 6.1 | 7.4 | 3.0 | 0 |
CfaAff × 0.13441.1.S1_s_at | EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 5.6 | 7.3 | 2.7 | 0 |
Cfa.2219.1.A1_at | ITGA6 | “integrin, alpha 6” | 7.5 | 8.3 | 2.2 | 0 |
*CfaAff × 0.8342.1.S1_at | PCDH9* | protocadherin 9 | 6.4 | 7.7 | 2.5 | 0 |
Cfa.9146.1.A1_at | PCDHAC2 | “protocadherin alpha subfamily C, 2” | 7.0 | 8.8 | 3.3 | 0 |
Cfa.9467.1.A1_at | RELN | reelin | 8.4 | 9.6 | 2.5 | 0 |
Calcium Binding | ||||||
*Cfa.7840.1.A1_at | CABP5* | calcium binding protein 5 | 8.6 | 11.2 | 4.7 | 0 |
*CfaAff × 0.14235.1.S1_s_at | CALB1* | “calbindin 1, 28kDa” | 6.3 | 10.0 | 6.8 | 0 |
Cfa.4168.2.S1_s_at | CALM1 | “calmodulin 1 (phosphorylase kinase, delta)” | 10.2 | 11.2 | 2.4 | 0 |
Cfa.20415.1.S1_at | HPCA | hippocalcin | 7.4 | 8.9 | 2.6 | 0 |
Cfa.10160.1.S1_at | PPP3CA | “protein phosphatase 3, catalytic subunit, alpha isoform” | 9.3 | 10.2 | 2.1 | 0 |
Cfa.10339.1.S1_at | PPP3R1 | “protein phosphatase 3, regulatory subunit B, alpha isoform” | 8.3 | 9.5 | 2.4 | 0 |
Cfa.10159.1.S1_at | PRKCB1 | “protein kinase C, beta 1” | 8.0 | 9.8 | 4.3 | 0 |
*Cfa.20981.1.S1_s_at | PVALB* | parvalbumin | 7.7 | 12.1 | 12.0 | 0 |
Calcium Channels | ||||||
*Cfa.1728.1.A1_s_at | CACNA2D3* | “Ca channel, voltage-dependent, alpha 2/delta 3 subunit” | 6.3 | 8.5 | 4.2 | 0 |
Cfa.1210.1.S1_at | CACNB3 | “Ca channel, voltage-dependent, beta 3 subunit” | 7.2 | 8.3 | 2.6 | 0 |
Cfa.269.1.A1_at | RYR2 | ryanodine receptor 2 | 5.3 | 7.0 | 3.2 | 0 |
CfaAff × 0.7090.1.S1_s_at | TRPC3 | “transient receptor potential cation channel, subfamily C, member 3” | 5.5 | 7.6 | 4.4 | 0 |
*CfaAff × 0.16161.1.S1_s_at | TRPM1* | “transient receptor potential cation channel, subfamily M, member 1” | 8.0 | 9.8 | 4.6 | 0 |
Neuronal Development | ||||||
*Cfa.9271.1.A1_at | CA10* | carbonic anhydrase X | 7.3 | 10.0 | 6.1 | 0 |
Cfa.10284.1.S1_s_at | CRMP1 | collapsin response mediator protein 1 | 6.1 | 7.1 | 2.1 | 0 |
CfaAff × 0.16492.1.S1_at | DNER | delta/notch-like EGF repeat containing | 8.8 | 9.7 | 2.0 | 0 |
Cfa.19360.1.S1_s_at | GNAO1 | “guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O” | 8.9 | 10.8 | 3.8 | 0 |
Cfa.7236.1.A1_s_at | NRXN1 | neurexin 1 | 7.1 | 9.4 | 4.2 | 0 |
*Cfa.10306.1.S1_at | OLFM1* | olfactomedin 1 | 8.6 | 10.0 | 2.5 | 0 |
CfaAff × 0.30602.1.S1_at | OLFM3 | olfactomedin 3 | 5.8 | 7.1 | 2.9 | 0 |
*Cfa.9934.1.A1_at | PCP4* | Purkinje cell protein 4 | 9.6 | 13.0 | 8.9 | 0 |
Cfa.15689.1.A1_at | PHYH | phytanoyl-CoA 2-hydroxylase | 7.1 | 9.2 | 4.3 | 0 |
CfaAff × 0.12766.1.S1_at | ROBO2 | “roundabout, axon guidance receptor, homolog 2” | 5.8 | 7.8 | 4.2 | 0 |
*CfaAff × 0.22493.1.S1_s_at | SERPINI1* | “serpin peptidase inhibitor, clade I, member 1” | 10.0 | 11.8 | 3.0 | 0 |
*Cfa.10644.1.A1_at | SH3GL3* | SH3-domain GRB2-like 3 | 6.8 | 9.0 | 5.2 | 0 |
*Cfa.1224.1.S1_at | TAGLN3* | transgelin 3 | 9.2 | 11.9 | 4.9 | 0 |
Cfa.174.1.S1_s_at | TFAP2B | transcription factor AP-2 beta | 6.9 | 9.6 | 4.4 | 0 |
Transcription Factors | ||||||
CfaAff × 0.12012.1.S1_at | GTF2H3 | “general transcription factor IIH, polypeptide 3, 34kDa” | 5.8 | 6.8 | 2.0 | 0.126704939 |
CfaAff × 0.28228.1.S1_at | ISL1 | ISL LIM homeobox 1 | 6.2 | 7.6 | 2.9 | 0 |
CfaAff × 0.5793.1.S1_s_at | MYT1L | myelin transcription factor 1-like | 5.5 | 6.8 | 2.4 | 0 |
CfaAff × 0.25541.1.S1_s_at | RORA | RAR-related orphan receptor A | 5.6 | 6.8 | 2.1 | 0.064323389 |
Cfa.5127.1.A1_s_at | RUNX1T1 | runt-related transcription factor 1 | 6.6 | 8.1 | 2.8 | 0 |
*CfaAff × 0.20645.1.S1_at | RXRG* | “retinoid X receptor, gamma” | 7.0 | 8.1 | 2.0 | 0 |
G-protein coupled receptor protein signaling | ||||||
Cfa.11087.1.A1_s_at | BAI3 | brain-specific angiogenesis inhibitor 3 | 7.2 | 8.9 | 3.3 | 0 |
*CfaAff × 0.8825.1.S1_s_at | CCK* | cholecystokinin | 5.4 | 7.2 | 2.7 | 0.126704939 |
Cfa.3870.1.A1_at | GAL | galanin prepropeptide | 5.6 | 8.0 | 5.5 | 0 |
*Cfa.3177.1.S1_at | GNAI1* | “guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1” | 9.8 | 11.2 | 2.8 | 0 |
*Cfa.10270.2.A1_at | GNG3* | “guanine nucleotide binding protein (G protein), gamma 3” | 7.5 | 9.5 | 3.6 | 0 |
CfaAff × 0.5919.1.S1_at | GPR85 | G protein-coupled receptor 85 | 7.0 | 9.0 | 4.2 | 0 |
CfaAff × 0.4269.1.S1_at | NXPH1 | neurexophilin 1 | 6.2 | 8.9 | 5.4 | 0 |
*Cfa.9688.1.A1_at | NXPH2* | neurexophilin 2 | 5.8 | 7.2 | 2.6 | 0 |
Cfa.1416.1.A1_at | PENK | proenkephalin | 5.7 | 7.4 | 3.2 | 0 |
Cfa.11233.1.A1_at | SSTR2 | somatostatin receptor 2 | 5.9 | 7.0 | 2.3 | 0.064323389 |
Cytoskeleton | ||||||
CfaAff × 0.5843.1.S1_s_at | ELMO1 | engulfment and cell motility 1 | 6.8 | 8.8 | 5.0 | 0 |
Cfa.6416.1.A1_at | SGCG | “sarcoglycan, gamma” | 6.0 | 7.0 | 2.1 | 0 |
*Cfa.11292.1.A1_at | TMOD1* | tropomodulin 1 | 6.9 | 8.8 | 3.0 | 0 |
*Cfa.10164.1.S1_at | TUBA4A* | “tubulin, alpha 4a” | 7.1 | 9.8 | 4.9 | 0 |
*Cfa.11276.1.S1_s_at | TUBB2A* | “tubulin, beta 2A” | 11.1 | 12.9 | 3.3 | 0 |